[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 Europe Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation--Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

March 2017 | 1273 pages | ID: E827EE54481EN
Venture Planning Group

US$ 17,730.00 US$ 19,700.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. This new 1, 273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Table of ContentsI. IntroductionII. Worldwide Technology and Market Overview A. DNA Sequencing B. DNA and RNA Probes Technology C. Detection Technologies D. Instrumentation Review E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip F. Pharmacogenomics G. Major ApplicationsIII. FranceIV. GermanyV. ItalyVI. SpainVII. U.K.VIII. Major Product Development OpportunitiesIX. Design Criteria for Decentralized Testing ProductsX. Alternative Market Penetration StrategiesXI. Potential Market Entry Barriers and RisksXII. Competitive AssessmentsXIII. Appendix Contains 1, 273 pages and 139 tables
COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

LIST OF TABLES

France AIDS Testing Market Estimated Sales by Major Supplier 2014
France Adenovirus Testing Market Estimated Sales by Major Supplier 2014
France Chlamydia Testing Market Estimated Sales by Major Supplier 2014
France CMV Testing Market Estimated Sales by Major Supplier 2014
France Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
France Hepatitis Testing Market Estimated Sales by Major Supplier 2014
France Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
France Herpes Testing Market Estimated Sales by Major Supplier 2014
France Influenza Testing Market Estimated Sales by Major Supplier 2014
France Meningitis Testing Market Estimated Sales by Major Supplier 2014
France Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
France RSV Testing Market Estimated Sales by Major Supplier 2014
France Shigella Testing Market Estimated Sales by Major Supplier 2014
Germany AIDS Testing Market Estimated Sales by Major Supplier 2014
Germany CMV Testing Market Estimated Sales by Major Supplier 2014
Germany EBV Testing Market Estimated Sales by Major Supplier 2014
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Germany Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Germany Herpes Testing Market Estimated Sales by Major Supplier 2014
Germany Influenza Testing Market Estimated Sales by Major Supplier 2014
Germany Meningitis Testing Market Estimated Sales by Major Supplier 2014
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
Germany Pneumonia Testing Market Estimated Sales by Major Supplier 2014
Germany RSV Testing Market Estimated Sales by Major Supplier 2014
Germany Rotavirus Testing Market Estimated Sales by Major Supplier 2014
Italy AIDS Testing Market Estimated Sales by Major Supplier 2014
Italy CMV Testing Market Estimated Sales by Major Supplier 2014
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Italy Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Italy Herpes Testing Market Estimated Sales by Major Supplier 2014
Italy Influenza Testing Market Estimated Sales by Major Supplier 2014
Italy Meningitis Testing Market Estimated Sales by Major Supplier 2014
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
Italy RSV Testing Market Estimated Sales by Major Supplier 2014
Spain AIDS Testing Market Estimated Sales by Major Supplier 2014
Spain Chlamydia Testing Market Estimated Sales by Major Supplier 2014
Spain CMV Testing Market Estimated Sales by Major Supplier 2014
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
Spain Hepatitis Testing Market Estimated Sales by Major Supplier 2014
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
Spain Herpes Testing Market Estimated Sales by Major Supplier 2014
Spain Influenza Testing Market Estimated Sales by Major Supplier 2014
Spain Meningitis Testing Market Estimated Sales by Major Supplier 2014
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
U.K. AIDS Testing Market Estimated Sales by Major Supplier 2014
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier 2014
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier 2014
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier 2014
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier 2014
U.K. Influenza Testing Market Estimated Sales by Major Supplier 2014
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier 2014
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier 2014
U.K. Shigella Testing Market Estimated Sales by Major Supplier 2014


More Publications